Put Options

19 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Jan 18, 2024

SELL
$57.42 - $83.61 $149,292 - $217,386
-2,600 Reduced 76.47%
800 $3,000
Q3 2023

Nov 07, 2023

BUY
$69.25 - $82.21 $166,200 - $197,303
2,400 Added 240.0%
3,400 $32,000
Q2 2023

Jul 18, 2023

SELL
$58.41 - $90.35 $251,162 - $388,505
-4,300 Reduced 81.13%
1,000 $12,000
Q1 2023

May 01, 2023

SELL
$58.39 - $75.0 $140,136 - $180,000
-2,400 Reduced 31.17%
5,300 $21,000
Q4 2022

Feb 07, 2023

SELL
$39.94 - $79.72 $403,394 - $805,172
-10,100 Reduced 56.74%
7,700 $29,000
Q3 2022

Oct 25, 2022

SELL
$36.06 - $69.85 $263,238 - $509,904
-7,300 Reduced 29.08%
17,800 $371,000
Q2 2022

Aug 04, 2022

BUY
$21.74 - $46.75 $380,450 - $818,125
17,500 Added 230.26%
25,100 $360,000
Q1 2022

Apr 14, 2022

SELL
$23.7 - $41.39 $237,000 - $413,900
-10,000 Reduced 56.82%
7,600 $326,000
Q4 2021

Jan 18, 2022

BUY
$30.7 - $43.36 $46,050 - $65,040
1,500 Added 9.32%
17,600 $484,000
Q3 2021

Oct 26, 2021

SELL
$19.91 - $68.26 $101,541 - $348,126
-5,100 Reduced 24.06%
16,100 $547,000
Q2 2021

Jul 19, 2021

BUY
$50.63 - $73.5 $379,725 - $551,250
7,500 Added 54.74%
21,200 $310,000
Q1 2021

Apr 26, 2021

BUY
$55.91 - $81.44 $95,047 - $138,448
1,700 Added 14.17%
13,700 $402,000
Q4 2020

Jan 21, 2021

BUY
$66.31 - $86.52 $92,834 - $121,128
1,400 Added 13.21%
12,000 $22,000
Q3 2020

Oct 27, 2020

BUY
$68.34 - $85.84 $75,174 - $94,424
1,100 Added 11.58%
10,600 $50,000
Q2 2020

Jul 22, 2020

SELL
$49.87 - $98.69 $129,662 - $256,594
-2,600 Reduced 21.49%
9,500 $48,000
Q1 2020

May 07, 2020

SELL
$41.2 - $101.31 $119,480 - $293,799
-2,900 Reduced 19.33%
12,100 $179,000
Q4 2019

Feb 06, 2020

BUY
$16.71 - $106.24 $100,260 - $637,440
6,000 Added 66.67%
15,000 $15,000
Q3 2019

Oct 28, 2019

SELL
$20.24 - $29.16 $159,896 - $230,364
-7,900 Reduced 46.75%
9,000 $47,000
Q1 2019

May 10, 2019

BUY
$2.63 - $16.34 $44,447 - $276,146
16,900 New
16,900 $2,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $4.16B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.